Earnings
Home›Earnings›Results›Hinge Health shares surge after Q2 results and bigger…
Hinge Health shares surge after Q2 results and bigger care expansion
Revenue jumped to $212.8 million in Q2, and the company raised its full-year revenue outlook to $856 million to $860 million as it expanded into migraine and digestive care.
Hinge Healths stock rose 91% in 2026 after the company reported strong Q2 results, alongside a push beyond its core musculoskeletal care platform, according to MarketBeat Ratings. Hinge Healths AI-powered platform uses smartphone cameras to track anatomical movement in real time to automate much of clinicians time for members with back, joint, and muscle pain. MarketBeat Ratings said the company is adding a Migraine Care Program and plans to expand further into digestive care through its pending acquisition of Cylinder Health, a virtual-first gastrointestinal provider. In its Q2 2026 earnings report, Hinge Health posted revenue of $212.8 million, up more than 52% year over year. Adjusted earnings per share were 59 cents, beating expectations of 28 cents by more than 100%, while operating margin rose to 29% and free cash flow increased to $100 million. The company also increased its full-year revenue outlook to a range of $856 million to $860 million, and raised its operating income forecast to $236 million to $244 million. MarketBeat Ratings attributed the updated guidance to stronger-than-expected enrollment yields, while noting the key risk is building two new care verticals on top of the business as it scales.